XM neposkytuje služby občanům Spojených států amerických.
L
L

LaboratoryCorporation


Novinky

U.S. Avidity Biosciences, Broadcom, Cara Therapeutics

U.S. RESEARCH ROUNDUP-Avidity Biosciences, Broadcom, Cara Therapeutics June 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avidity Biosciences, Broadcom and Cara Therapeutics, on Thursday. HIGHLIGHTS * Avidity Biosciences Inc RNA.O : Leerink Partners raises target price to $56 from $38 * Broadcom Inc AVGO.O : TD Cowen raises target price to $1,750 from $1,500 * Cara Therapeutics Inc CARA.O : Canaccord Genuity cut
B
B
C
C
G
M
C
A
D
I
L

U.S. Abbvie, Lionsgate Studios, UnitedHealth Group

U.S. RESEARCH ROUNDUP-Abbvie, Lionsgate Studios, UnitedHealth Group June 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbvie, Lionsgate Studios and UnitedHealth Group, on Wednesday. HIGHLIGHTS * Abbvie Inc ABBV.N : HSBC raises to buy from hold * Crowdstrike Holdings Inc CRWD.O : BTIG cuts target price to $402 from $432 * Lionsgate Studios LION.O : Seaport Research Partners initiates coverage with neutral rating
A
S
A
I
L
P

Sherlock Bio evaluates over-the-counter rapid test for STIs, aims launch in 2025

Sherlock Bio evaluates over-the-counter rapid test for STIs, aims launch in 2025 By Bhanvi Satija May 30 (Reuters) - Sherlock Bio said on Thursday it had begun a trial of its over-the-counter rapid test for detecting sexually transmitted infections (STI) such as chlamydia and gonorrhea, and aims to launch it by mid-2025. The Massachusetts-based startup expects to become the first to launch a prescription-free rapid test for the infections, which affected 2.3 million people in the United States i
L

U.S. Elevance Health, Wesco International, WW Grainger

U.S. RESEARCH ROUNDUP-Elevance Health, Wesco International, WW Grainger May 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies including Elevance Health, Wesco International and WW Grainger, on Thursday. HIGHLIGHTS * Cigna Group CI.N : JP Morgan raises target price to $435 from $432 * Elevance Health Inc ELV.N : JP Morgan raises target price to $631 from $628 * Uipath Inc PATH.N : TD Cowen cuts to hold from buy * Wesco Internati
A
C
C
E
F
S
A
E
H
W
A
L
U

Some of the biggest splits in Corporate America

FACTBOX-Some of the biggest splits in Corporate America Adds DuPont, Masimo Corp, Lionsgate, Citigroup, Edwards Lifesciences, Western Digital and AT&T ; Updates Labcorp, 3M, Kellogg, J&J and General Electric Co May 23 (Reuters) - Chemical maker DuPont DD.N has become the latest multinational to break up its business, announcing a plan to split the firm into three publicly traded companies.
A
C
E
K
P
W
D
C
L
O

Laboratory Corporation Of America Holdings Files For Debt Shelf

BRIEF-Laboratory Corporation Of America Holdings Files For Debt Shelf May 17 (Reuters) - Laboratory Corporation of America Holdings LH.N : LABORATORY CORPORATION OF AMERICA HOLDINGS FILES FOR DEBT SHELF; SIZE NOT DISCLOSED- SEC FILING LABORATORY CORPORATION OF AMERICA HOLDINGS: UNIT LABCORP HOLDINGS INC FILES FOR MIXED SHELF ; SIZE NOT DISCLOSED-SE
L

U.S. STOCKS Cracker Barrel, Robinhood Markets, DuPont

BUZZ-U.S. STOCKS ON THE MOVE-Cracker Barrel, Robinhood Markets, DuPont Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were little changed on Friday as investors took a breather from the week's rally driven by growing expectations of U.S.
A
C
C
G
R
S
A
L
T
U
U
U
A
D
L

U.S. STOCKS Tilray Brands, Arbutus Biopharma, Coinbase

BUZZ-U.S. STOCKS ON THE MOVE-Tilray Brands, Arbutus Biopharma, Coinbase Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were little changed on Friday as investors took a breather from the week's rally driven by growing expectations of U.S.
A
C
C
E
G
M
N
R
S
A
T
U
U
U
A
D
L

U.S. STOCKS Advanced Micro Devices, United Airlines, GameStop

BUZZ-U.S. STOCKS ON THE MOVE-Advanced Micro Devices, United Airlines, GameStop Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were set to open marginally higher on Friday, looking to extend this week's rally on growing expectations of U.S.
A
G
M
N
R
A
T
U
U
A
D
L

U.S. STOCKS DXC Technology, Darden Restaurants, Doximity

BUZZ-U.S. STOCKS ON THE MOVE-DXC Technology, Darden Restaurants, Doximity Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures were treading water on Friday, signaling a pause on Wall Street after a rally driven by expectations of interest-rate cuts this year.
A
C
G
R
T
U
D
L

Ascension hack could be 'somewhat disruptive' for LabCorp, brokerage says

BUZZ-Ascension hack could be 'somewhat disruptive' for LabCorp, brokerage says ** Brokerage Evercore ISI says size and duration of a recent cyberattack at hospital operator Ascension could be "somewhat disruptive" for LabCorp LH.N in 2024 ** Evercore estimates that the non-profit hospital operator will contribute about $600 mln revenue to LH in 202
L

Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy

BRIEF-Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy May 15 (Reuters) - Laboratory Corporation of America Holdings LH.N : LABCORP INTRODUCES FIRST TRIMESTER SCREENING TEST TO ASSESS PREECLAMPSIA RISK DURING PREGNANCY Source text for Eikon: ID:nPnZ1S6Ta Further company coverage: LH.N
L

Invitae Receives Court Approval For Sale To Labcorp

BRIEF-Invitae Receives Court Approval For Sale To Labcorp May 7 (Reuters) - Labcorp and Invitae: INVITAE RECEIVES COURT APPROVAL FOR SALE TO LABCORP LABCORP - LABCORP WILL ACQUIRE SELECT ASSETS OF INVITAE ON A GOING CONCERN BASIS FOR $239 MILLION LABCORP - INVITAE AND LABCORP ANTICIPATE SALE WILL BE COMPLETED IN Q3 OF 2024 Source text for Eikon: ID
L

US FDA tightens scrutiny of lab-developed tests with new rule

UPDATE 3-US FDA tightens scrutiny of lab-developed tests with new rule adds FDA executive comments in paragraphs 4-5, analyst comments in paragraph 10-11 April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday tightened regulations for clinical laboratories with a new rule that gives it more oversight of diagnostic tests developed by them.
L

US FDA publishes final rule for laboratory developed tests

US FDA publishes final rule for laboratory developed tests April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory. Reporting by Mariam Sunny in Bengaluru; Editin
L

Labcorp Receives FDA Approval For First Companion Diagnostic For Use With Pfizer's Newly Approved Gene Therapy To Treat Patients With Hemophilia B

BRIEF-Labcorp Receives FDA Approval For First Companion Diagnostic For Use With Pfizer's Newly Approved Gene Therapy To Treat Patients With Hemophilia B April 29 (Reuters) - Laboratory Corporation of America Holdings LH.N : LABCORP RECEIVES FDA APPROVAL FOR FIRST COMPANION DIAGNOSTIC FOR USE WITH PFIZER'S NEWLY APPROVED GENE THERAPY TO TREAT PATIEN
L

U.S. STOCKS Loar, Regeneron, Intel

BUZZ-U.S. STOCKS ON THE MOVE-Loar, Regeneron, Intel Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks slumped on Thursday as most megacaps fell after Meta Platforms' quarterly results, while sentiment was shaken amid signs of persistent inflation that dampened hopes of the Federal Reserve easing monetary policy anytime soon.
A
B
B
B
C
C
G
I
M
N
N
P
R
T
L
T
U
U
D
R
S
T
W
C
D
L
T

Labcorp falls on weak forecast for life sciences unit

BUZZ-Labcorp falls on weak forecast for life sciences unit ** Laboratory services provider Labcorp's LH.N shares fall as much as 5.7% to near six-month low of $196.11 ** Company's Q1 adj EPS of $3.68 beats est of $3.48 - LSEG ** Labcorp's weaker forecast for its life sciences unit, namely continued high cancellations faced by its early development services for drugs, could be weighing on shares - brokerage Baird ** Shares move in line with SPDR S&P Biotech ETF's XBI.P moves, which is down 2.8% -
L

Laboratory Corporation of America Holdings reports results for the quarter ended in March - Earnings Summary

Laboratory Corporation of America Holdings reports results for the quarter ended in March - Earnings Summary Laboratory Corporation of America Holdings LH.N reported quarterly adjusted earnings of $3.68​​ per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of $3.82. The mean expectation of sixteen analysts for the quarter was for earnings of $3.48 per share.
L

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: EPH, Shareholder Capital, GTCR, DMCI Holdings, Updates: BHP Group April 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** BHP Group BHP.AX bid $38.8 billion for Anglo American AAL.L , offering a deal to forge the world's biggest copper miner and driving its smaller rival's shares 13% higher.
C
C
C
A
L



Podmínky

Populární aktiva

Zřeknutí se odpovědnosti: Subjekty skupiny XM Group poskytují služby a přístup do naší online obchodní platformy v režimu „execution-only”, což osobám umožní prohlížet a/nebo použít obsah, dostupný zde nebo prostřednictvím webové stránky, který není určený ke změně nebo šíření. Na takový přístup a použití se vždy vztahují: (i) Všeobecné obchodní podmínky; (ii) Upozornění na rizika; a (iii) Úplné zřeknutí se odpovědnosti. Takový obsah je proto poskytovaný pouze jako obecné informace. Mějte především na paměti, že obsah naší online obchodní platformy není ani žádostí, ani nabídkou vstupu do jakýchkoliv transakcí na finančních trzích. Obchodování na jakémkoliv finančním trhu zahrnuje významnou úroveň rizika pro váš kapitál.

Veškerý materiál, zveřejněný na naší online obchodní platformě, je určený pouze pro vzdělávací/informační účely a neobsahuje ani by neměl být považovaný za finanční, investiční, daňové nebo obchodní rady a doporučení, ani záznamy o našich obchodních cenách, nebo nabídku transakce s jakýmikoliv finančními instrumenty, či nevyžádadnou propagaci pro vaši osobu.

Jakýkoliv obsah třetích stran a také obsah, připravený společností XM, jako jsou názory, novinky, výzkum, analýzy, ceny, další informace nebo odkazy na webové stránky třetích stran, které jsou zobrazeny na tomto webu, jsou poskytovány v neupravené verzi jako obecný tržní komentář, a nepředstavují investiční radu. Pokud je jakýkoliv obsah uváděný jako investiční výzkum, musíte si uvědomit a přijmout, že tento obsah nebyl určený a nebyl připravený v souladu se zákonnými požadavky, vytvořenými pro podporu nezávislosti investičního výzkumu, a jako takový by měl být podle příslušných zákonů a předpisu považovaný pouze za marketingovou komunikaci. Ujistěte se, že jste si přečetli a plně rozumíte našemu Oznámení o seznámení se s riziky a investičním výzkumu, který není nezávislý, týkající se výše uvedených informací, a ke kterým lze přejít zde.

Upozornění na riziko: Váš kapitál je ohrožený. Produkty s pákovým efektem nemusí být vhodné pro každého. Zvažte prosím naše Zveřejnění rizik.